<code id='35E23D29F3'></code><style id='35E23D29F3'></style>
      • <acronym id='35E23D29F3'></acronym>
      <center id='35E23D29F3'><center id='35E23D29F3'><tfoot id='35E23D29F3'></tfoot></center><abbr id='35E23D29F3'><dir id='35E23D29F3'><tfoot id='35E23D29F3'></tfoot><noframes id='35E23D29F3'>
      • <optgroup id='35E23D29F3'><strike id='35E23D29F3'><sup id='35E23D29F3'></sup></strike><code id='35E23D29F3'></code></optgroup>
        5. <b id='35E23D29F3'><label id='35E23D29F3'><select id='35E23D29F3'><dt id='35E23D29F3'><span id='35E23D29F3'></span></dt></select></label></b><u id='35E23D29F3'></u>
          <i id='35E23D29F3'><strike id='35E23D29F3'><tt id='35E23D29F3'><pre id='35E23D29F3'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / explore / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-06 09:25:19 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：54585
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Laying a path for careers in science
                                
                            
          Next article：  
                                      
                                          Duchenne breakthrough therapy leaves behind pioneering families
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles